nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—DRD5—attention deficit hyperactivity disorder	0.166	0.212	CbGaD
Cabergoline—ADRA2C—attention deficit hyperactivity disorder	0.157	0.2	CbGaD
Cabergoline—DRD4—attention deficit hyperactivity disorder	0.0851	0.108	CbGaD
Cabergoline—HTR1B—attention deficit hyperactivity disorder	0.0756	0.0961	CbGaD
Cabergoline—DRD3—attention deficit hyperactivity disorder	0.0734	0.0933	CbGaD
Cabergoline—DRD1—attention deficit hyperactivity disorder	0.0721	0.0916	CbGaD
Cabergoline—ADRA2A—attention deficit hyperactivity disorder	0.067	0.0851	CbGaD
Cabergoline—DRD2—attention deficit hyperactivity disorder	0.0508	0.0646	CbGaD
Cabergoline—HTR2A—attention deficit hyperactivity disorder	0.0393	0.0499	CbGaD
Cabergoline—HTR7—locus ceruleus—attention deficit hyperactivity disorder	0.00468	0.0912	CbGeAlD
Cabergoline—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00292	0.0569	CbGeAlD
Cabergoline—HTR7—autonomic nervous system—attention deficit hyperactivity disorder	0.00249	0.0485	CbGeAlD
Cabergoline—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00155	0.0302	CbGeAlD
Cabergoline—DRD5—forebrain—attention deficit hyperactivity disorder	0.00121	0.0237	CbGeAlD
Cabergoline—ADRA1D—forebrain—attention deficit hyperactivity disorder	0.000974	0.019	CbGeAlD
Cabergoline—DRD1—forebrain—attention deficit hyperactivity disorder	0.000928	0.0181	CbGeAlD
Cabergoline—Pergolide—DRD5—attention deficit hyperactivity disorder	0.000808	0.113	CrCbGaD
Cabergoline—DRD4—brain—attention deficit hyperactivity disorder	0.000765	0.0149	CbGeAlD
Cabergoline—Pergolide—ADRA2C—attention deficit hyperactivity disorder	0.000762	0.107	CrCbGaD
Cabergoline—HTR1B—forebrain—attention deficit hyperactivity disorder	0.000752	0.0146	CbGeAlD
Cabergoline—HTR1D—forebrain—attention deficit hyperactivity disorder	0.000728	0.0142	CbGeAlD
Cabergoline—HTR2C—forebrain—attention deficit hyperactivity disorder	0.000721	0.014	CbGeAlD
Cabergoline—ADRB1—forebrain—attention deficit hyperactivity disorder	0.000708	0.0138	CbGeAlD
Cabergoline—DRD3—nervous system—attention deficit hyperactivity disorder	0.000704	0.0137	CbGeAlD
Cabergoline—Lisuride—DRD5—attention deficit hyperactivity disorder	0.000702	0.0983	CrCbGaD
Cabergoline—DRD3—central nervous system—attention deficit hyperactivity disorder	0.000678	0.0132	CbGeAlD
Cabergoline—HTR2B—forebrain—attention deficit hyperactivity disorder	0.000677	0.0132	CbGeAlD
Cabergoline—Lisuride—ADRA2C—attention deficit hyperactivity disorder	0.000662	0.0927	CrCbGaD
Cabergoline—DRD5—nervous system—attention deficit hyperactivity disorder	0.00066	0.0128	CbGeAlD
Cabergoline—HTR1B—cardiovascular system—attention deficit hyperactivity disorder	0.000636	0.0124	CbGeAlD
Cabergoline—DRD5—central nervous system—attention deficit hyperactivity disorder	0.000635	0.0124	CbGeAlD
Cabergoline—HTR1D—cardiovascular system—attention deficit hyperactivity disorder	0.000616	0.012	CbGeAlD
Cabergoline—DRD1—midbrain—attention deficit hyperactivity disorder	0.000613	0.0119	CbGeAlD
Cabergoline—HTR1A—forebrain—attention deficit hyperactivity disorder	0.000607	0.0118	CbGeAlD
Cabergoline—ADRB1—cardiovascular system—attention deficit hyperactivity disorder	0.000598	0.0116	CbGeAlD
Cabergoline—HTR7—forebrain—attention deficit hyperactivity disorder	0.00058	0.0113	CbGeAlD
Cabergoline—HTR2B—cardiovascular system—attention deficit hyperactivity disorder	0.000573	0.0112	CbGeAlD
Cabergoline—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.00056	0.0109	CbGeAlD
Cabergoline—DRD2—forebrain—attention deficit hyperactivity disorder	0.000548	0.0107	CbGeAlD
Cabergoline—ADRA1B—nervous system—attention deficit hyperactivity disorder	0.000541	0.0105	CbGeAlD
Cabergoline—DRD3—brain—attention deficit hyperactivity disorder	0.000538	0.0105	CbGeAlD
Cabergoline—ADRA1D—nervous system—attention deficit hyperactivity disorder	0.000529	0.0103	CbGeAlD
Cabergoline—ADRA1B—central nervous system—attention deficit hyperactivity disorder	0.00052	0.0101	CbGeAlD
Cabergoline—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.000513	0.00999	CbGeAlD
Cabergoline—ADRA1D—central nervous system—attention deficit hyperactivity disorder	0.000509	0.00991	CbGeAlD
Cabergoline—DRD5—brain—attention deficit hyperactivity disorder	0.000504	0.00981	CbGeAlD
Cabergoline—DRD1—nervous system—attention deficit hyperactivity disorder	0.000504	0.00981	CbGeAlD
Cabergoline—HTR1B—midbrain—attention deficit hyperactivity disorder	0.000497	0.00967	CbGeAlD
Cabergoline—HTR7—cardiovascular system—attention deficit hyperactivity disorder	0.00049	0.00955	CbGeAlD
Cabergoline—DRD1—central nervous system—attention deficit hyperactivity disorder	0.000485	0.00945	CbGeAlD
Cabergoline—HTR1D—midbrain—attention deficit hyperactivity disorder	0.000481	0.00936	CbGeAlD
Cabergoline—HTR2C—midbrain—attention deficit hyperactivity disorder	0.000476	0.00927	CbGeAlD
Cabergoline—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.000473	0.00921	CbGeAlD
Cabergoline—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.000425	0.00828	CbGeAlD
Cabergoline—Pergolide—DRD4—attention deficit hyperactivity disorder	0.000414	0.0579	CrCbGaD
Cabergoline—ADRA1B—brain—attention deficit hyperactivity disorder	0.000413	0.00805	CbGeAlD
Cabergoline—HTR1B—nervous system—attention deficit hyperactivity disorder	0.000408	0.00795	CbGeAlD
Cabergoline—ADRA1D—brain—attention deficit hyperactivity disorder	0.000404	0.00787	CbGeAlD
Cabergoline—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000401	0.0078	CbGeAlD
Cabergoline—HTR1D—nervous system—attention deficit hyperactivity disorder	0.000395	0.0077	CbGeAlD
Cabergoline—HTR1B—central nervous system—attention deficit hyperactivity disorder	0.000393	0.00765	CbGeAlD
Cabergoline—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000391	0.00762	CbGeAlD
Cabergoline—DRD1—brain—attention deficit hyperactivity disorder	0.000385	0.0075	CbGeAlD
Cabergoline—ADRB1—nervous system—attention deficit hyperactivity disorder	0.000384	0.00748	CbGeAlD
Cabergoline—HTR7—midbrain—attention deficit hyperactivity disorder	0.000383	0.00746	CbGeAlD
Cabergoline—HTR1D—central nervous system—attention deficit hyperactivity disorder	0.000381	0.00741	CbGeAlD
Cabergoline—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.000377	0.00734	CbGeAlD
Cabergoline—ADRB1—central nervous system—attention deficit hyperactivity disorder	0.00037	0.0072	CbGeAlD
Cabergoline—HTR2B—nervous system—attention deficit hyperactivity disorder	0.000368	0.00716	CbGeAlD
Cabergoline—Pergolide—HTR1B—attention deficit hyperactivity disorder	0.000367	0.0515	CrCbGaD
Cabergoline—DRD2—midbrain—attention deficit hyperactivity disorder	0.000362	0.00705	CbGeAlD
Cabergoline—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000362	0.00704	CbGeAlD
Cabergoline—Lisuride—DRD4—attention deficit hyperactivity disorder	0.000359	0.0503	CrCbGaD
Cabergoline—Pergolide—DRD3—attention deficit hyperactivity disorder	0.000357	0.05	CrCbGaD
Cabergoline—HTR2B—central nervous system—attention deficit hyperactivity disorder	0.000354	0.00689	CbGeAlD
Cabergoline—ADRA2C—midbrain—attention deficit hyperactivity disorder	0.000352	0.00685	CbGeAlD
Cabergoline—Pergolide—DRD1—attention deficit hyperactivity disorder	0.00035	0.049	CrCbGaD
Cabergoline—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000329	0.00642	CbGeAlD
Cabergoline—Pergolide—ADRA2A—attention deficit hyperactivity disorder	0.000325	0.0456	CrCbGaD
Cabergoline—Lisuride—HTR1B—attention deficit hyperactivity disorder	0.000319	0.0447	CrCbGaD
Cabergoline—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000317	0.00618	CbGeAlD
Cabergoline—HTR7—nervous system—attention deficit hyperactivity disorder	0.000315	0.00613	CbGeAlD
Cabergoline—HTR1B—brain—attention deficit hyperactivity disorder	0.000312	0.00608	CbGeAlD
Cabergoline—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.00031	0.00604	CbGeAlD
Cabergoline—Lisuride—DRD3—attention deficit hyperactivity disorder	0.00031	0.0434	CrCbGaD
Cabergoline—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000306	0.00596	CbGeAlD
Cabergoline—Lisuride—DRD1—attention deficit hyperactivity disorder	0.000304	0.0426	CrCbGaD
Cabergoline—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.000304	0.00591	CbGeAlD
Cabergoline—HTR7—central nervous system—attention deficit hyperactivity disorder	0.000303	0.0059	CbGeAlD
Cabergoline—HTR1D—brain—attention deficit hyperactivity disorder	0.000302	0.00588	CbGeAlD
Cabergoline—HTR2C—brain—attention deficit hyperactivity disorder	0.000299	0.00583	CbGeAlD
Cabergoline—DRD2—nervous system—attention deficit hyperactivity disorder	0.000298	0.0058	CbGeAlD
Cabergoline—HTR7—cerebellum—attention deficit hyperactivity disorder	0.000296	0.00577	CbGeAlD
Cabergoline—ADRB1—brain—attention deficit hyperactivity disorder	0.000294	0.00572	CbGeAlD
Cabergoline—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000292	0.00569	CbGeAlD
Cabergoline—ADRA2C—nervous system—attention deficit hyperactivity disorder	0.000289	0.00564	CbGeAlD
Cabergoline—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000287	0.00558	CbGeAlD
Cabergoline—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.000286	0.00556	CbGeAlD
Cabergoline—Lisuride—ADRA2A—attention deficit hyperactivity disorder	0.000282	0.0396	CrCbGaD
Cabergoline—HTR2B—brain—attention deficit hyperactivity disorder	0.000281	0.00547	CbGeAlD
Cabergoline—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.000281	0.00547	CbGeAlD
Cabergoline—DRD2—cerebellum—attention deficit hyperactivity disorder	0.00028	0.00545	CbGeAlD
Cabergoline—ADRA2C—central nervous system—attention deficit hyperactivity disorder	0.000279	0.00543	CbGeAlD
Cabergoline—ADRA2C—cerebellum—attention deficit hyperactivity disorder	0.000272	0.0053	CbGeAlD
Cabergoline—HTR1A—brain—attention deficit hyperactivity disorder	0.000252	0.0049	CbGeAlD
Cabergoline—Pergolide—DRD2—attention deficit hyperactivity disorder	0.000247	0.0346	CrCbGaD
Cabergoline—HTR7—brain—attention deficit hyperactivity disorder	0.000241	0.00469	CbGeAlD
Cabergoline—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000239	0.00465	CbGeAlD
Cabergoline—ADRA1A—brain—attention deficit hyperactivity disorder	0.000232	0.00452	CbGeAlD
Cabergoline—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000231	0.0045	CbGeAlD
Cabergoline—DRD2—brain—attention deficit hyperactivity disorder	0.000228	0.00443	CbGeAlD
Cabergoline—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.000222	0.00433	CbGeAlD
Cabergoline—ADRA2C—brain—attention deficit hyperactivity disorder	0.000221	0.00431	CbGeAlD
Cabergoline—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.000217	0.00423	CbGeAlD
Cabergoline—Lisuride—DRD2—attention deficit hyperactivity disorder	0.000214	0.03	CrCbGaD
Cabergoline—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000196	0.00382	CbGeAlD
Cabergoline—Pergolide—HTR2A—attention deficit hyperactivity disorder	0.000191	0.0267	CrCbGaD
Cabergoline—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000189	0.00368	CbGeAlD
Cabergoline—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000185	0.0036	CbGeAlD
Cabergoline—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000182	0.00354	CbGeAlD
Cabergoline—ADRA2A—brain—attention deficit hyperactivity disorder	0.000177	0.00344	CbGeAlD
Cabergoline—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000175	0.00341	CbGeAlD
Cabergoline—Lisuride—HTR2A—attention deficit hyperactivity disorder	0.000166	0.0232	CrCbGaD
Cabergoline—HTR2A—brain—attention deficit hyperactivity disorder	0.00015	0.00292	CbGeAlD
Cabergoline—HTR7—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.31e-06	6.01e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—TPH2—attention deficit hyperactivity disorder	9.29e-06	6e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.29e-06	6e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.25e-06	5.97e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	9.23e-06	5.96e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	9.2e-06	5.94e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	9.19e-06	5.93e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	9.18e-06	5.93e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.18e-06	5.93e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	9.14e-06	5.9e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—DPYD—attention deficit hyperactivity disorder	9.14e-06	5.9e-05	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	9.1e-06	5.88e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	9.09e-06	5.87e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	9.08e-06	5.86e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.06e-06	5.85e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.06e-06	5.85e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	9.06e-06	5.85e-05	CbGpPWpGaD
Cabergoline—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	9.05e-06	5.84e-05	CbGpPWpGaD
Cabergoline—HTR2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	9.05e-06	5.84e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.99e-06	5.8e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	8.96e-06	5.79e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	8.95e-06	5.78e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	8.93e-06	5.77e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.93e-06	5.77e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.91e-06	5.76e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	8.9e-06	5.74e-05	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	8.86e-06	5.72e-05	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	8.84e-06	5.71e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	8.82e-06	5.7e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	8.78e-06	5.67e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	8.75e-06	5.65e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.75e-06	5.65e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.66e-06	5.59e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	8.64e-06	5.58e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.61e-06	5.56e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.6e-06	5.55e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	8.54e-06	5.51e-05	CbGpPWpGaD
Cabergoline—DRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.53e-06	5.51e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.51e-06	5.49e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.49e-06	5.48e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.42e-06	5.44e-05	CbGpPWpGaD
Cabergoline—DRD3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.42e-06	5.43e-05	CbGpPWpGaD
Cabergoline—ADRA1D—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.42e-06	5.43e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.38e-06	5.41e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.33e-06	5.38e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.29e-06	5.35e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	8.27e-06	5.34e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	8.25e-06	5.33e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.24e-06	5.32e-05	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	8.23e-06	5.32e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	8.22e-06	5.31e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.22e-06	5.3e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.19e-06	5.29e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	8.18e-06	5.28e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.16e-06	5.27e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.14e-06	5.26e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.09e-06	5.22e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	8.07e-06	5.21e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	8.05e-06	5.2e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.03e-06	5.18e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	8.03e-06	5.18e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.02e-06	5.18e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.02e-06	5.18e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.92e-06	5.11e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	7.92e-06	5.11e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	7.92e-06	5.11e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.91e-06	5.11e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	7.89e-06	5.1e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.89e-06	5.09e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	7.85e-06	5.07e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.75e-06	5e-05	CbGpPWpGaD
Cabergoline—ADRB1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	7.67e-06	4.95e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.66e-06	4.95e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.64e-06	4.94e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.64e-06	4.94e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	7.64e-06	4.93e-05	CbGpPWpGaD
Cabergoline—ADRA2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	7.6e-06	4.91e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.58e-06	4.9e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—TPH2—attention deficit hyperactivity disorder	7.54e-06	4.87e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.54e-06	4.87e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.53e-06	4.86e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.53e-06	4.86e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	7.52e-06	4.85e-05	CbGpPWpGaD
Cabergoline—ADRB2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	7.5e-06	4.84e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	7.48e-06	4.83e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.44e-06	4.8e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.42e-06	4.79e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	7.42e-06	4.79e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.38e-06	4.76e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.36e-06	4.75e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.36e-06	4.75e-05	CbGpPWpGaD
Cabergoline—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	7.34e-06	4.74e-05	CbGpPWpGaD
Cabergoline—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	7.3e-06	4.71e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.26e-06	4.69e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.23e-06	4.67e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	7.21e-06	4.66e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	7.15e-06	4.62e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.13e-06	4.6e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.1e-06	4.59e-05	CbGpPWpGaD
Cabergoline—ADRA2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	7.1e-06	4.58e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.07e-06	4.56e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	7.06e-06	4.56e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.01e-06	4.53e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.01e-06	4.52e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.01e-06	4.52e-05	CbGpPWpGaD
Cabergoline—ADRA1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	6.99e-06	4.51e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	6.96e-06	4.5e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	6.93e-06	4.48e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.93e-06	4.47e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.92e-06	4.47e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.92e-06	4.47e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	6.9e-06	4.46e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.9e-06	4.46e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.9e-06	4.45e-05	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.89e-06	4.45e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.87e-06	4.43e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	6.82e-06	4.4e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	6.81e-06	4.4e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.71e-06	4.33e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	6.68e-06	4.31e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.68e-06	4.31e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	6.66e-06	4.3e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.65e-06	4.29e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	6.63e-06	4.28e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.57e-06	4.24e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.56e-06	4.24e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.53e-06	4.22e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.5e-06	4.19e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.45e-06	4.16e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.45e-06	4.16e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	6.45e-06	4.16e-05	CbGpPWpGaD
Cabergoline—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	6.44e-06	4.16e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.44e-06	4.16e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.42e-06	4.14e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.38e-06	4.12e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.38e-06	4.12e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Hemostasis—EP300—attention deficit hyperactivity disorder	6.37e-06	4.11e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.35e-06	4.1e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	6.34e-06	4.1e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.33e-06	4.08e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.31e-06	4.07e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.25e-06	4.03e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.25e-06	4.03e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.21e-06	4.01e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.21e-06	4.01e-05	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	6.21e-06	4.01e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	6.21e-06	4.01e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.18e-06	3.99e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.17e-06	3.98e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.11e-06	3.94e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.11e-06	3.94e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.08e-06	3.92e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.06e-06	3.91e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.03e-06	3.89e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.03e-06	3.89e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.01e-06	3.88e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6e-06	3.87e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.96e-06	3.85e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Hemostasis—EP300—attention deficit hyperactivity disorder	5.95e-06	3.84e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.92e-06	3.82e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.91e-06	3.82e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.87e-06	3.79e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.85e-06	3.78e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.84e-06	3.77e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.84e-06	3.77e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.82e-06	3.76e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.82e-06	3.76e-05	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.77e-06	3.72e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.75e-06	3.71e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.74e-06	3.71e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.64e-06	3.64e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.63e-06	3.64e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—COMT—attention deficit hyperactivity disorder	5.63e-06	3.63e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.62e-06	3.63e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.59e-06	3.61e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—MAOA—attention deficit hyperactivity disorder	5.59e-06	3.61e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.54e-06	3.58e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.46e-06	3.52e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.44e-06	3.51e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.43e-06	3.5e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.42e-06	3.5e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.37e-06	3.47e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.36e-06	3.46e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.35e-06	3.45e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.31e-06	3.43e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.3e-06	3.42e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.28e-06	3.41e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.28e-06	3.41e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.26e-06	3.39e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.24e-06	3.38e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.21e-06	3.36e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.17e-06	3.34e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.17e-06	3.34e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.1e-06	3.29e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.08e-06	3.28e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.04e-06	3.26e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.88e-06	3.15e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.85e-06	3.13e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.85e-06	3.13e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	4.83e-06	3.12e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.75e-06	3.07e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.74e-06	3.06e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.66e-06	3.01e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.58e-06	2.95e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	4.57e-06	2.95e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	4.54e-06	2.93e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.52e-06	2.92e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.52e-06	2.92e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.42e-06	2.85e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.11e-06	2.66e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.08e-06	2.63e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.02e-06	2.6e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.94e-06	2.54e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.92e-06	2.53e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.81e-06	2.46e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.75e-06	2.42e-05	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.65e-06	2.36e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.46e-06	2.23e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.33e-06	2.15e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	3.21e-06	2.07e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.21e-06	2.07e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	3.16e-06	2.04e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.09e-06	2e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.94e-06	1.9e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.81e-06	1.82e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.8e-06	1.8e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.74e-06	1.77e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.69e-06	1.74e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.57e-06	1.66e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.57e-06	1.66e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.45e-06	1.58e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.42e-06	1.57e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—EP300—attention deficit hyperactivity disorder	2.41e-06	1.56e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.39e-06	1.54e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.39e-06	1.54e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.18e-06	1.41e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.16e-06	1.39e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.13e-06	1.38e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.08e-06	1.35e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.07e-06	1.34e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.02e-06	1.3e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.99e-06	1.28e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	1.96e-06	1.27e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	1.95e-06	1.26e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	1.93e-06	1.25e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.83e-06	1.18e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.8e-06	1.16e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.76e-06	1.14e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.64e-06	1.06e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	8.35e-07	5.39e-06	CbGpPWpGaD
